VANDAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vandazole, and what generic alternatives are available?
Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vandazole
A generic version of VANDAZOLE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for VANDAZOLE
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,195 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VANDAZOLE |
| Drug Sales Revenues: | Drug sales revenues for VANDAZOLE |
| What excipients (inactive ingredients) are in VANDAZOLE? | VANDAZOLE excipients list |
| DailyMed Link: | VANDAZOLE at DailyMed |
Recent Clinical Trials for VANDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New York Medical College | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for VANDAZOLE
US Patents and Regulatory Information for VANDAZOLE
VANDAZOLE is protected by one US patents.
Patents protecting VANDAZOLE
Vaginal pharmaceutical compositions and methods for preparing them
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | VANDAZOLE | metronidazole | GEL;VAGINAL | 021806-001 | May 20, 2005 | BX | RX | No | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Premature patent expiration for: VANDAZOLE
Expiration due to failure to pay maintenance fee
| Patent Number | Tradename | Expiration Date |
|---|---|---|
| See Plans and Pricing | VANDAZOLE | See Plans and Pricing |
